PAINWeek 2018

Improving Communication Between Patients With Chronic Pain and Their Providers

Improving Communication Between Patients With Chronic Pain and Their Providers

By

Dr Zacharoff offered several tips to PAINWeek attendees to help improve their communication with patients.

Psychological Interventions for the Management of Chronic Pain

Psychological Interventions for the Management of Chronic Pain

By

Dr Prasad highlights the importance of interdisciplinary approaches to the management of chronic pain.

Benefits of NSAIDs as Part of Multimodal Analgesia Regimen in Children

Benefits of NSAIDs as Part of Multimodal Analgesia Regimen in Children

By

Perioperative and emergency department use of non-steroidal anti-inflammatory drugs as part of a multimodal analgesia regimen may improve pain control in pediatric populations and avoid opioid-related adverse events.

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

Lower Dose DFN-11 for Episodic Migraine Associated With Fewer Side Effects

By

DFN-11, a 3 mg subcutaneous (SC) sumatriptan autoinjector, may provide an alternative to SC sumatriptan 6 mg for individuals with episodic migraine, as it was found to have a lower incidence of side effects and injection site reactions.

Clinical Pathway Effective in Reducing Discharge Opioids After Pediatric Orthopedic Surgery

Clinical Pathway Effective in Reducing Discharge Opioids After Pediatric Orthopedic Surgery

By

A clinical pathway designed to reduce variations in opioid prescriptions for acute pain in children discharged after orthopedic surgery, was found to be effective in reducing prescriptions while maintaining analgesia.

Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects

Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects

By

Dr Harden provides an overview of the use of ketamine as an analgesic and its associated side effects.

Tips for Reducing Opioid Withdrawal Symptoms: A Clinical Commentary

Tips for Reducing Opioid Withdrawal Symptoms: A Clinical Commentary

By

Clinicians are reducing or discontinuing opioid therapy for patients in light of the 2016 guidelines for opioid prescribing by primary care physicians issued by the CDC.

Lower Rates of Abuse With Nucynta ER vs Other ER Opioids

Lower Rates of Abuse With Nucynta ER vs Other ER Opioids

By

Nucynta extended-release (ER) may be associated with lower rates of abuse compared with other ER opioid medications.

Lasmiditan May Be Effective as Acute Migraine Treatment

Lasmiditan May Be Effective as Acute Migraine Treatment

By

Lasmiditan was found to be more effective compared with placebo in eliminating pain and other symptoms associated with headache in individuals with migraine.

ZTlido Bioequivalent to Lidoderm Patch, With Better Adhesion Profile

ZTlido Bioequivalent to Lidoderm Patch, With Better Adhesion Profile

By

A topical lidocaine delivery system (ZTlido™) may be safe, effective, and well tolerated, and be bioequivalent to a lidocaine patch (Lidoderm®, 5%, 700 mg), with superior adhesion properties.

Should Drug Testing Be Implemented Before Prescribing Opioids and Benzodiazepines?

Should Drug Testing Be Implemented Before Prescribing Opioids and Benzodiazepines?

By

Clinicians should get their patients tested for drugs before prescribing them opioid or benzodiazepine medications—and on a regular basis when patients are on those drugs—as drug-drug interactions may be associated with risks.

Use and Overuse of Acute Medications Common Among Migraineurs

Use and Overuse of Acute Medications Common Among Migraineurs

By

Investigator analyzed the number of scripts and days of therapy in patients with migraine to determine use and frequency of overuse.

Naldemedine is Safe, Well Tolerated in Treatment of Opioid-Induced Constipation

Naldemedine is Safe, Well Tolerated in Treatment of Opioid-Induced Constipation

By

Naldemedine is a peripherally acting μ-opioid receptor antagonist approved for opioid-induced constipation in adults with chronic non-cancer related pain.

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

Fremanezumab May Be Efficacious for Comorbid Chronic Migraine and Depression

By

Fremanezumab may be efficacious for the prophylaxis of chronic migraine in individuals with comorbid migraine and moderate/moderate to severe depression.

Small-Fiber Neuropathies: Etiologies, Diagnostic Tests, and Treatments

Small-Fiber Neuropathies: Etiologies, Diagnostic Tests, and Treatments

By

Dr Argoff presented an overview of diagnostic tests and available treatments for small-fiber polyneuropathies.

Ibuprofen Superior to Acetaminophen Plus Codeine for Pain Relief After Molar Extraction

Ibuprofen Superior to Acetaminophen Plus Codeine for Pain Relief After Molar Extraction

By

A single dose of ibuprofen was superior to acetaminophen plus codeine for reducing pain 6 hours after a third molar extraction.

Novel Oxycodone Abuse-Deterrant Formulation Shows Comparable Efficacy With IR Oxycodone

Novel Oxycodone Abuse-Deterrant Formulation Shows Comparable Efficacy With IR Oxycodone

By

Oxycodone ARIR (RoxyBondTM), a novel abuse-deterrent formulation of immediate-release oxycodone, may have comparable safety and efficacy to IR oxycodone.

Opioid Use in Osteoarthritis Linked to Worse Pain Interference, Functioning

Opioid Use in Osteoarthritis Linked to Worse Pain Interference, Functioning

By

In patients with osteoarthritis, chronic pain is a primary symptom that may limit daily activities and impair function.

Few With Acute Migraine Take Triptans, Many Discontinue the Drug

Few With Acute Migraine Take Triptans, Many Discontinue the Drug

By

Few patients were found to take triptan medications to treat acute migraine, and a majority of those who had, discontinued the treatment due to side effects.

Eluxadoline May Improve Abdominal Pain in Irritable Bowel Syndrome With Diarrhea

Eluxadoline May Improve Abdominal Pain in Irritable Bowel Syndrome With Diarrhea

By

For patients with irritable bowel syndrome with diarrhea who had an inadequate response to loperamide, eluxadoline may effectively reduce abdominal pain over a 12-week period.

Risk for Intentional Tapentadol Abuse Analyzed With the RADARS Poison Center Program

Risk for Intentional Tapentadol Abuse Analyzed With the RADARS Poison Center Program

By

Despite its low rate of abuse, tapentadol may still represent a public health burden.

Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine

Fremanezumab May Have Long-Term Efficacy as a Prophylactic for Chronic Migraine

By

Fremanezumab treatment may be efficacious in reducing the number of monthly headache days in the long-term in people with chronic migraine.

Integrating Psychological Interventions Into Chronic Pain Management

Integrating Psychological Interventions Into Chronic Pain Management

By

Dr Darnall presented an overview of the role played by psychology and behavioral interventions in the management of chronic pain.

Leveraging Machine Learning to Develop Objective Biomarkers for Pain

Leveraging Machine Learning to Develop Objective Biomarkers for Pain

By

Dr Mackey discussed potential applications of machine learning technology in chronic pain management and research.

Examining the Prevalence and Assessment of Mental Health Disorders in Chronic Pain

Examining the Prevalence and Assessment of Mental Health Disorders in Chronic Pain

By

Dr Cosio presented results from a preliminary study examining the prevalence of mental health disorders in veterans with chronic pain.

Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis

Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis

By

Dr Glick gave an overview of direct and indirect generators of neck pain and exposed some of the deficiencies of regional examinations for the differential diagnosis of this condition.

Acceptance and Commitment Therapy for Chronic Pain Shows Benefit

Acceptance and Commitment Therapy for Chronic Pain Shows Benefit

By

Investigators presented the results from a preliminary study examining the effect of an acceptance and commitment therapy in individuals with chronic pain.

PAINWeek 2018 Conference: Preview of Live Coverage

PAINWeek 2018 Conference: Preview of Live Coverage

By

Clinical Pain Advisor will be providing live coverage of the 12th annual PAINWeek conference, held September 4-8, 2018, in Las Vegas, Nevada.

Sign Up for Free e-Newsletters